Mildef Crete (ROCO:3213) Other Stockholders Equity: NT$327 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:3213 Mildef Crete Inc ROCO:3213
69 GF Score
Price NT$126.50
GF Value NT$88.92
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Mildef Crete Other Stockholders Equity?

Mildef Crete ROCO:3213 -1.56% 69 Other Stockholders Equity is NT$327 Mil as of Mar. 2026. GuruFocus rates ROCO:3213 with a GF Score™ of 69/100 and a GF Value™ of NT$88.92 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Mildef Crete's Other Stockholders Equity for the quarter that ended in Mar. 2026 was NT$327 Mil.

Mildef Crete's quarterly Other Stockholders Equity declined from Sep. 2025 (NT$691 Mil) to Dec. 2025 (NT$295 Mil) but then increased from Dec. 2025 (NT$295 Mil) to Mar. 2026 (NT$327 Mil).

Mildef Crete's annual Other Stockholders Equity increased from Dec. 2023 (NT$242 Mil) to Dec. 2024 (NT$670 Mil) but then declined from Dec. 2024 (NT$670 Mil) to Dec. 2025 (NT$295 Mil).

Mildef Crete Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Mildef Crete's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mildef Crete Other Stockholders Equity Chart

Mildef Crete Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 105.05 380.83 241.65 670.40 295.32

Mildef Crete Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,256.75 867.48 690.82 295.32 327.25
ROCO:3213
69GF Score
Mildef Crete Inc ROCO:3213
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mildef Crete Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of NT$327 Mil mean?
Mildef Crete (ROCO:3213) has a Other Stockholders Equity of NT$327 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Mildef Crete and its competitors.
Is Mildef Crete's Other Stockholders Equity too high?
Mildef Crete's current Other Stockholders Equity is NT$327 Mil. Overall, Mildef Crete has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mildef Crete's Other Stockholders Equity compare to DELL and ANET?
Mildef Crete's Other Stockholders Equity of NT$327 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Hardware company?
A good Other Stockholders Equity depends on the Hardware industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Mildef Crete and its competitors. Mildef Crete's current Other Stockholders Equity is NT$327 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mildef Crete stock overvalued right now?
Based on GuruFocus' analysis, Mildef Crete (ROCO:3213) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$88.92, compared to a current price of NT$126.50 — trading 42.3% above its estimated fair value. The current Other Stockholders Equity is NT$327 Mil. Mildef Crete's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Mildef Crete (ROCO:3213), the current Other Stockholders Equity is NT$327 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mildef Crete (ROCO:3213) Overvalued in 2026?

Based on GuruFocus' analysis, Mildef Crete stock appears to be overvalued. The current stock price of NT$126.50 is trading 42.3% above its estimated GF Value™ of NT$88.92. GuruFocus considers Mildef Crete to be Significantly Overvalued.

Key valuation signals for ROCO:3213:

  • Other Stockholders Equity: NT$327 Mil
  • GF Value™: NT$88.92 vs. price of NT$126.50 (42.3% above fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the ROCO:3213 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mildef Crete Business Description

Address Beishen Road, 7th Floor, No. 250, Section 3, Shenkeng District, New Taipei City, TWN, 222
Mildef Crete Inc is an international company with a focus on the design, manufacturing, and marketing of rugged devices in laptop, handheld, and tablet form factors, as well as their associated accessories. Its product portfolio comprises mobile workstations, rugged computers, customised rugged controllers, tablets, handheld devices, and related accessories such as docklite, keyboards, battery chargers, military connectors, etc. The majority of the Group's revenue is generated from the sale of business and rugged computers. Geographically, it generates maximum revenue from Asia, and the rest from Europe, Oceania, and the Americas.
69GF Score

Get the complete analysis for ROCO:3213

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$126.50
Price
NT$88.92
GF Value